Monday, November 8, 2021

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Pfizer says COVID-19 pill cut hospital, death risk by 90%:

On Friday, Pfizer released preliminary results of its study of 775 adults. Patients who received the company’s drug along with another antiviral shortly after showing COVID-19 symptoms had an 89% reduction in their combined rate of hospitalization or death after a month, compared to patients taking a dummy pill. Fewer than 1% of patients taking the drug needed to be hospitalized and no one died. In the comparison group, 7% were hospitalized and there were seven deaths.

“We were hoping that we had something extraordinary, but it’s rare that you see great drugs come through with almost 90% efficacy and 100% protection for death,” said Dr. Mikael Dolsten, Pfizer’s chief scientific officer, in an interview.

Does "high risk" include the elderly?  And what are the 20 percent side effects they're seeing?

No comments:

Post a Comment

New Concerning Variant: B.1.1.529 - by Katelyn Jetelina - Your Local Epidemiologist

This substack looks pretty good. New Concerning Variant: B.1.1.529 - by Katelyn Jetelina - Your Local Epidemiologist :  B.1.1.529 has 32 mut...